breast cancer and glp 1 drugs GLP-1 cut risk by 30%? Not so fast Ozempic and similar weight-loss drugs
Description
J Clin Neurosci 95:172179
The administration of the triple agonist resulted in the improvement of steatohepatitis in a dose-dependent fashion, with some female mice showing a complete resolution
Step 3: If the PA is approved, that's that and you can access your medication (yay!)
Lebrun, L
Additionally, they activate the AMPK pathway in liver cells, which promotes fatty acid oxidation and reduces lipid accumulation (lipogenesis), offering potential benefits for non-alcoholic fatty liver disease (NAFLD) (Zheng et al., 2024)
